Christopher G Goetz Selected Research

sarizotan

4/2008	Placebo influences on dyskinesia in Parkinson's disease.
1/2007	Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
3/2004	Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher G Goetz Research Topics

Disease

46	Parkinson Disease (Parkinson's Disease) 02/2024 - 03/2002
15	Dyskinesias (Dyskinesia) 01/2023 - 05/2000
8	Movement Disorders (Movement Disorder) 01/2024 - 05/2002
8	Hallucinations (Hallucination) 03/2014 - 08/2004
7	Parkinsonian Disorders (Parkinsonism) 10/2019 - 05/2003
7	Dementia (Dementias) 05/2012 - 01/2006
5	Psychotic Disorders (Schizoaffective Disorder) 01/2024 - 12/2006
5	Tremor (Tremors) 01/2022 - 06/2006
3	Cognitive Dysfunction 02/2024 - 10/2008
2	Tics (Tic) 05/2023 - 08/2010
2	Chronic Disease (Chronic Diseases) 01/2022 - 05/2010
2	Fragile X Tremor Ataxia Syndrome 04/2020 - 01/2010
2	Erectile Dysfunction 05/2017 - 10/2011
2	Disease Progression 12/2014 - 05/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2012 - 02/2007
2	Fatigue 10/2011 - 05/2010
2	Alzheimer Disease (Alzheimer's Disease) 02/2007 - 12/2003
2	Dystonia (Limb Dystonia) 10/2006 - 05/2000
2	Hysteria 05/2004 - 04/2003
1	Inflammation (Inflammations) 01/2023
1	Synucleinopathies 01/2022
1	Multiple System Atrophy 01/2022
1	Urolithiasis 02/2014
1	Gout 02/2014
1	Essential Tremor (Essential Tremors) 11/2013
1	Atrophy 05/2012
1	Constipation 10/2011
1	Gambling (Pathological Gambling) 10/2011
1	Disorders of Excessive Somnolence (Hypersomnia) 10/2011
1	Orthostatic Hypotension (Postural Hypotension) 10/2011
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2011

Drug/Important Bio-Agent (IBA)

13	Levodopa (L Dopa)FDA LinkGeneric 01/2023 - 03/2004
8	Antipsychotic Agents (Antipsychotics)IBA 09/2011 - 02/2006
4	Amantadine (Aman)FDA LinkGeneric 01/2017 - 07/2007
4	Biomarkers (Surrogate Marker)IBA 05/2014 - 05/2003
4	Clozapine (Clozaril)FDA LinkGeneric 10/2011 - 06/2009
3	Inosine FDA Link 01/2022 - 02/2014
3	Uric Acid (Urate)IBA 01/2022 - 02/2014
3	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 01/2010
3	Dopamine Agents (Dopaminergic Agents)IBA 08/2010 - 01/2007
3	sarizotanIBA 04/2008 - 03/2004
2	Glucosylceramidase (Glucocerebrosidase)IBA 02/2024 - 01/2022
2	Coenzyme A (CoA)IBA 01/2024 - 02/2023
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 10/2011
2	Memantine (Namenda)FDA Link 04/2020 - 10/2011
2	Sildenafil Citrate (Viagra)FDA Link 05/2017 - 10/2011
2	salicylhydroxamic acid (SHAM)IBA 08/2015 - 07/2012
2	Pramipexole (Mirapex)FDA LinkGeneric 10/2011 - 10/2011
2	Pergolide (Permax)FDA Link 10/2011 - 10/2011
2	Cholinergic Antagonists (Anticholinergics)IBA 09/2011 - 01/2006
2	Cholecystokinin (Pancreozymin)IBA 08/2011 - 08/2004
2	Messenger RNA (mRNA)IBA 01/2010 - 01/2007
2	Opioid Analgesics (Opioids)IBA 08/2008 - 07/2007
2	Selegiline (E250)FDA LinkGeneric 05/2005 - 03/2002
1	12- (4'- azido- 2'- nitrophenoxy)dodecanoyl- coenzyme AIBA 01/2024
1	antineoplaston A10 (A 10)IBA 05/2023
1	PrebioticsIBA 01/2023
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022
1	Butyric Acid (Butanoic Acid)IBA 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	Succinic Acid (Succinate)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Isradipine (Dynacirc)FDA LinkGeneric 10/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	IncretinsIBA 01/2021
1	AntioxidantsIBA 10/2019
1	Topiramate (Topamax)FDA LinkGeneric 01/2017
1	6- fluoro- 2- (4- (pyridin- 2- yl)but- 3- yn- 1- yl)imidazo(1,2- a)pyridineIBA 01/2016
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2016
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2016
1	NeurturinIBA 08/2015
1	Antidepressive Agents (Antidepressants)IBA 10/2011
1	Carbidopa (Lodosyn)FDA LinkGeneric 10/2011
1	Desipramine (Pertofrane)FDA LinkGeneric 10/2011
1	Domperidone (Domperidon)IBA 10/2011
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 10/2011
1	FludrocortisoneIBA 10/2011
1	Fluoxetine (Prozac)FDA LinkGeneric 10/2011
1	Galantamine (Galanthamine)FDA LinkGeneric 10/2011
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 10/2011
1	Amitriptyline (Elavil)FDA LinkGeneric 10/2011
1	MelatoninIBA 10/2011
1	Methylphenidate (Ritalin)FDA LinkGeneric 10/2011
1	Cabergoline FDA LinkGeneric 10/2011
1	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 10/2011
1	Nortriptyline (Aventyl)FDA LinkGeneric 10/2011

Therapy/Procedure

15	Therapeutics 01/2021 - 05/2002
7	Activities of Daily Living (ADL) 01/2017 - 10/2008
6	Deep Brain Stimulation 02/2024 - 12/2015
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2022
2	Transplantation 02/2009 - 09/2003
2	Hypnosis (Mesmerism) 05/2004 - 04/2003
1	Telerehabilitation 02/2024
1	Aftercare (After-Treatment) 01/2019
1	PD protocol 12/2015
1	Neurosurgical Procedures 07/2012
1	Tai Ji (Tai Chi Chuan) 01/2012